Nyxoah SA Ordinary Shares (NYXH)
Stock · NASDAQ · Health Care
$1.6as of 8/28/2026
Price chart
Open in TradingViewAbout NYXH
Nyxoah SA, a medical technology company, focuses on the development and commercialization of solutions to treat obstructive sleep apnea. Its lead solution is the Genio system, a hypoglossal neurostimulations therapy for obstructive sleep apnea. The company was incorporated in 2009 and is headquartered in Mont-Saint-Guibert, Belgium.
- Sector
- Health Care
- Industry
- Medical/Dental Instruments
- Employees
- 153
- Website
- www.nyxoah.com/
Fundamentals
- 1-day range
- $1.6$1.67
- Market cap
- $57.20M
- P/E (trailing)
- —
- P/E (forward)
- -1.70
- EPS (trailing)
- $-2.16
- Dividend yield
- —
- Beta
- 1.04
- Avg. volume
- 329.7K
52-week range
$1.14$6.36
Next earnings: November 5, 2026 · EPS estimate $-0.33confirmed
Forecasts
3 analyst ratings
Buy 79%
Hold 21%
Sell 0%
1-year price forecast
High
$11.05
+593.1%
Median
$4.05
+154.1%
Low
$3.04
+90.6%
Nyxoah SA Ordinary Shares Competitors
Chosen by industry and closest market cap.
- NYXHNyxoah SA Ordinary Shares$1.6▲ 1.59%Market cap $57.20MP/E —$1.14$6.36
- DRIODarioHealth Corp. Common Stock$6.55▼ 3.25%Market cap $56.88MP/E —$5.84$17.74
- QTEXQTREX Quantum Ltd. Ordinary Shares$0.8259▼ 2.14%Market cap $59.05MP/E —$0.283$3.85
- DXRDaxor Corporation Common Stock$10.2▲ 6.14%Market cap $61.18MP/E 6.42$8.56$14.76
- MDAISpectral AI Inc. Class A Common Stock$1.58▼ 3.37%Market cap $52.83MP/E —$1.18$2.97
- XTNTXtant Medical Holdings Inc. Common Stock$0.4055▲ 22.88%Market cap $62.09MP/E 23.84$0.2702$0.95
- SNWVSANUWAVE Health Inc. Common Stock$4.64▼ 0.43%Market cap $51.59MP/E 2.56$4.5$44.94
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| NYXH Nyxoah SA Ordinary Shares | $57.20M | — | $1.6 | ▲ 1.59% | $1.14$6.36 |
| DRIO DarioHealth Corp. Common Stock | $56.88M | — | $6.55 | ▼ 3.25% | $5.84$17.74 |
| QTEX QTREX Quantum Ltd. Ordinary Shares | $59.05M | — | $0.8259 | ▼ 2.14% | $0.283$3.85 |
| DXR Daxor Corporation Common Stock | $61.18M | 6.42 | $10.2 | ▲ 6.14% | $8.56$14.76 |
| MDAI Spectral AI Inc. Class A Common Stock | $52.83M | — | $1.58 | ▼ 3.37% | $1.18$2.97 |
| XTNT Xtant Medical Holdings Inc. Common Stock | $62.09M | 23.84 | $0.4055 | ▲ 22.88% | $0.2702$0.95 |
| SNWV SANUWAVE Health Inc. Common Stock | $51.59M | 2.56 | $4.64 | ▼ 0.43% | $4.5$44.94 |
P/E shows — for peers not currently carrying a live signal of their own.
Latest news
- Cantor Fitzgerald Maintains Overweight on Nyxoah, Lowers Price Target to $6benzinga · 8/17/2026
- Cantor Fitzgerald Maintains Overweight on Nyxoah, Lowers Price Target to $6Benzinga · 8/17/2026
- Piper Sandler Reiterates Overweight on Nyxoah, Lowers Price Target to $6Benzinga · 8/6/2026
- Nyxoah SA (NYXH) (Q2 2026) Earnings Call Highlights: US Revenue Surges 22% Sequentially, $110M ...Yahoo · 8/6/2026
- Nyxoah Q2 Earnings Call HighlightsYahoo · 8/6/2026
- Nyxoah SA (NYXH) Q2 2026 Earnings Call TranscriptSeekingAlpha · 8/5/2026
- Nyxoah Reports Second Quarter and First Half 2026 Financial and Operating ResultsYahoo · 8/5/2026
- Nyxoah Lowers FY2026 Sales Guidance from $42.156M-$46.840M to $41.852M-$46.502M vs $44.410M EstBenzinga · 8/5/2026
- Nyxoah Q2 EPS $(0.67) Misses $(0.47) Estimate, Sales $8.922M Miss $9.030M EstimateBenzinga · 8/5/2026
See the full, filterable feed with live charts on the MarketWall dashboard.